NMJ agents Flashcards
-Curium
Isoquinolones: NM blocking drugs: nondepolarizing: must be given Parenterally: compete at nAChR: H release
-Curonium
Steroid derivatives: NM blocking drugs: nondepolarizing: Must be given Parenterally: compete at nACHR: less H release
all metabolized to 3, 17, or 3,17 hydroxy derivatives: less potent
Dantrolene
Spasmolytic: block RyR Ca channel: no heart effect
malignant hyperthermia
Botulinum Toxin
Spasmolytic: cleaves SNARE: blocks ACh relase
cervical dystonia and blepharospam
Ambenonium
Donepezil
Echothiophate
AChEI
Edrophonium
Galantamine
Tacrine
AChEI
Neostigmine
Physostigmine
Pyridostigmine
Rivastigmine
AChEI
physostigmine crosses BBB
Pyridostigmine in AChEI poisoning PROPHYLAXIS
Anti-muscarinics
Atropine
Glycopyrrolate
Cholinesterase Reactivators
Pralidoxime: used to counteract organophosphorus/cholinesterase complex at nAChR
Atropine only works at mAChR
Succinylcholine
NM blocking: Depolarizing: ultra short duration: nAChR agonist: phase 1 (depolarizing) block, then phase II (desensitiing) block = similar to non depolarized block
Reversal of Neuromuscular Blockade
Neo or pyridostigmine
Edrophonium (no transmitter release effects)
Antimuscarinics given (minimize bradycardia, nausea, vomit, bronchoconstriction)
Adverse effects of nondepolarizing agents
histamine release (wheals) (tubocurarine lots of H release)
Drug-Drug interactions in NM blockade
potentiate anesthetics (isoflurane)
Aminoglycoside Abx enhance NM block
Atracurium
intermediate: hofmann elimination: laudanosine product crosses BBB - seizures
less histamine release than others
Cisatracurium
intermediate, isomer of atracurium, fewer side effects
used w/ renal impairment, no CV effects